Imadul Islam

1.8k total citations
55 papers, 1.1k citations indexed

About

Imadul Islam is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Imadul Islam has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 16 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Imadul Islam's work include Synthesis and Biological Evaluation (7 papers), Computational Drug Discovery Methods (7 papers) and Chemokine receptors and signaling (6 papers). Imadul Islam is often cited by papers focused on Synthesis and Biological Evaluation (7 papers), Computational Drug Discovery Methods (7 papers) and Chemokine receptors and signaling (6 papers). Imadul Islam collaborates with scholars based in Saudi Arabia, United States and India. Imadul Islam's co-authors include Edward B. Skibo, WILLIAM G. SCHULZ, Karen May, Sundarababu Baskaran, Srinivasan Chandrasekaran, Meina Liang, Richard Horuk, Ameen Ghannam, Michael M. Morrissey and John G. Bauman and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Imadul Islam

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imadul Islam Saudi Arabia 22 427 381 281 183 114 55 1.1k
Dean Stamos United States 21 598 1.4× 704 1.8× 209 0.7× 124 0.7× 107 0.9× 30 1.4k
Keizo Koya United States 19 406 1.0× 627 1.6× 205 0.7× 105 0.6× 18 0.2× 31 1.2k
Karson S. Putt United States 21 254 0.6× 699 1.8× 413 1.5× 214 1.2× 38 0.3× 42 1.5k
Jeffrey P. Krise United States 24 241 0.6× 802 2.1× 248 0.9× 76 0.4× 44 0.4× 37 1.6k
Anne M. Whalen United States 18 249 0.6× 948 2.5× 602 2.1× 265 1.4× 34 0.3× 22 1.9k
John Porter United Kingdom 19 241 0.6× 548 1.4× 213 0.8× 119 0.7× 35 0.3× 38 1.1k
Lawrence J. Wilson United States 24 717 1.7× 743 2.0× 305 1.1× 153 0.8× 112 1.0× 59 1.6k
Ho H. Lee New Zealand 21 397 0.9× 741 1.9× 324 1.2× 380 2.1× 22 0.2× 40 1.6k
Edward R. Bacon United States 18 453 1.1× 321 0.8× 83 0.3× 120 0.7× 38 0.3× 57 988
Cristina Lewis United States 16 219 0.5× 935 2.5× 319 1.1× 93 0.5× 53 0.5× 26 1.4k

Countries citing papers authored by Imadul Islam

Since Specialization
Citations

This map shows the geographic impact of Imadul Islam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imadul Islam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imadul Islam more than expected).

Fields of papers citing papers by Imadul Islam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imadul Islam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imadul Islam. The network helps show where Imadul Islam may publish in the future.

Co-authorship network of co-authors of Imadul Islam

This figure shows the co-authorship network connecting the top 25 collaborators of Imadul Islam. A scholar is included among the top collaborators of Imadul Islam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imadul Islam. Imadul Islam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wijesinghe, Dayanjan S., et al.. (2025). Genomics-driven drug repurposing and novel targets identification for sickle cell disease in Saudi patients. Frontiers in Bioinformatics. 5. 1671626–1671626.
4.
Mashhour, Abdullah, Pearl Chan, Rabih O. Al‐Kaysi, et al.. (2025). First-in-class inhibitors of Nsp15 endoribonuclease of SARS-CoV-2: Modeling, synthesis, and enzymatic assay of thiazolidinedione and rhodanine analogs. Journal of Biological Chemistry. 301(8). 110409–110409.
5.
Islam, Imadul, et al.. (2024). Unraveling the Frontiers of Nanomedicine: Exploring Advancements and Envisioning the Future. Asian Journal of Pharmaceutical Research and Development. 12(4). 126–132. 1 indexed citations
6.
Sapkal, Suryakant B., Ilaria D’Agostino, Mattia Mori, et al.. (2024). Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors. ACS Medicinal Chemistry Letters. 15(6). 972–978. 1 indexed citations
7.
8.
Carta, Veronica, et al.. (2024). Solar-Powered Molecular Crystal Motor Based on an Anthracene–Thiazolidinedione Photoisomerization Reaction. Journal of the American Chemical Society. 146(28). 18836–18840. 19 indexed citations
9.
Suliman, Rasha Saad, Sahar S. Alghamdi, Rizwan Ali, et al.. (2022). Distinct Mechanisms of Cytotoxicity in Novel Nitrogenous Heterocycles: Future Directions for a New Anti-Cancer Agent. Molecules. 27(8). 2409–2409. 6 indexed citations
10.
El‐Sawy, Eslam R., et al.. (2011). Synthesis of A New Series of N-Substituted-3-Indolyl-Heterocycles for Antimicrobial Evaluation. Egyptian Journal of Chemistry. 54(1). 141–154. 1 indexed citations
11.
Adler, Marc, Brad O. Buckman, Judi Bryant, et al.. (2008). Structures of potent selective peptide mimetics bound to carboxypeptidase B. Acta Crystallographica Section D Biological Crystallography. 64(2). 149–157. 17 indexed citations
12.
Islam, Imadul, Greg Brown, Judi Bryant, et al.. (2007). Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX-517. Bioorganic & Medicinal Chemistry Letters. 17(14). 3819–3825. 35 indexed citations
13.
Islam, Imadul, Judi Bryant, Karen May, et al.. (2006). 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa). Bioorganic & Medicinal Chemistry Letters. 17(5). 1349–1354. 25 indexed citations
14.
Haskell, Christopher A., Richard Horuk, Meina Liang, et al.. (2005). Identification and Characterization of a Potent, Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR8. Molecular Pharmacology. 69(1). 309–316. 27 indexed citations
15.
Islam, Imadul, John Finn, Ping Du, et al.. (2002). Discovery of potent and selective small molecule NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(13). 1767–1769. 16 indexed citations
16.
Liang, Meina, Mary P. Rosser, Howard P. Ng, et al.. (2000). Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor. European Journal of Pharmacology. 389(1). 41–49. 41 indexed citations
17.
Du, Ping, John Salon, Joseph A. Tamm, et al.. (1997). Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites. Protein Engineering Design and Selection. 10(2). 109–117. 48 indexed citations
18.
Islam, Imadul, K. T. Chong, T. J. MCQUADE, et al.. (1994). Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors. Journal of Medicinal Chemistry. 37(2). 293–304. 10 indexed citations
19.
Islam, Imadul, Edward B. Skibo, Robert T. Dorr, & David S. Alberts. (1991). Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents. Journal of Medicinal Chemistry. 34(10). 2954–2961. 61 indexed citations
20.
Islam, Imadul, et al.. (1984). A study of the reaction of N-chlorosuccinimide with indoles and its analytical application. Talanta. 31(8). 642–644. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dean Stamos Breakdown of academic impact, for papers by Keizo Koya Breakdown of academic impact, for papers by Karson S. Putt Breakdown of academic impact, for papers by Jeffrey P. Krise Breakdown of academic impact, for papers by Anne M. Whalen Breakdown of academic impact, for papers by John Porter Breakdown of academic impact, for papers by Lawrence J. Wilson Breakdown of academic impact, for papers by Ho H. Lee Breakdown of academic impact, for papers by Edward R. Bacon Breakdown of academic impact, for papers by Cristina Lewis
Rankless by CCL
2026